In conclusion, high-risk group seems like an immune-desert tumor with high level of LGALS9, PD-1, and PD-L1, which was consistent with the former result of LGALS9 inducing the positive regulation of immune tolerance. The gene discussed is CD274; the disease is neoplasm.